Aimei Health Technology Co., Ltd. extended the deadline to consummate its initial business combination with United Hydrogen from July 6, 2026, to August 6, 2026. This twentieth extension was funded by a $34,330.96 deposit into the public shareholders' trust account. To fund this payment, the company issued a non-interest-bearing unsecured promissory note for $34,330.96 to Aimei Health Ltd, which is payable upon the closing of the business combination or convertible into private units at $10.00 per unit. The company is a special purpose acquisition company (SPAC) operating in the healthcare technology sector.